Onto Innovation Inc. — Form 10-K Summary
Period clarification: The supplied filing is for the fiscal year ended December 31, 2019, filed February 25, 2020—not a 2017 Q4 report. Comparisons with 2018 and 2017 require caution: the October 25, 2019 merger with Nanometrics was accounted for as a reverse acquisition, so historical results are Rudolph’s and Nanometrics’ results are included only from October 26, 2019.
Business context and reporting period
Onto Innovation designs and supplies semiconductor process-control equipment and software, including inspection, metrology and advanced-packaging lithography systems, plus parts and services. It reported one operating segment. The merger combined Rudolph and Nanometrics in an all-stock transaction; each legacy shareholder group owned approximately half of the combined company immediately after closing.
Financial performance and liquidity
| Metric | FY2019 | FY2018 | FY2017 |
|---|---|---|---|
| Revenue | $305.9 million | $273.8 million | $255.1 million |
| Gross profit / margin | $135.0 million / 44.1% | $148.3 million / 54.2% | $134.6 million / 52.8% |
| Operating income (loss) | $(5.0) million | $51.1 million | $59.3 million |
| Net income | $1.9 million | $45.1 million | $32.9 million |
| Diluted EPS | $0.06 | $1.74 | $1.27 |
| Cash from operating activities | $18.1 million | $35.1 million | $64.2 million |
Revenue rose 11.7% in 2019, mainly because the reported period includes Nanometrics after the merger; management said semiconductor capital-equipment spending declines partly offset that addition. Systems and software generated 84% of revenue, parts 11%, and services 5%. Gross margin fell sharply, and operating expenses rose to $140.1 million from $97.2 million.
At year-end, cash and cash equivalents were $130.7 million and marketable securities were $189.6 million, totaling $320.2 million; working capital was $555.9 million. Operating cash flow declined to $18.1 million. The company reported no debt balance; it had an unused, securities-secured credit line with approximately $91.3 million available at a stated 3.3% rate. Operating lease liabilities had a present value of $24.9 million. Management expected existing cash, securities and credit availability to cover anticipated needs for the next 12 months.
Material changes, outlook and risks
- Merger and unusual costs: 2019 included $14.8 million of merger expenses in general and administrative costs, $10.4 million of amortization (versus $1.5 million in 2018), and a $15.4 million cost-of-revenue charge from the acquisition-date inventory fair-value step-up. The company also recorded excess and obsolete inventory charges; the inventory note reports $10.8 million for the year, including $5.9 million in Q4.
- Quarterly weakness: Q4 2019 revenue was $120.6 million, but the quarter recorded a $22.4 million pretax loss and a $17.8 million net loss, versus Q4 2018 net income of $8.1 million. The merger materially affects the quarterly comparison.
- 2020 outlook: Management cited industry-analyst forecasts for semiconductor capital-equipment spending to increase approximately 5%–8% in 2020 versus 2019. This is an industry forecast, not company revenue or earnings guidance.
- Demand and customer concentration: The business is cyclical and dependent on customer capital spending. TSMC and SK Hynix represented 13.4% and 13.1% of 2019 revenue, respectively; customers are not obligated to continue buying. Backlog was approximately $71.7 million, but orders may be delayed or canceled.
- Integration and operations: Management identified merger integration, realization of anticipated synergies, retention of customers and employees, and possible integration costs as risks. Other material exposures include limited-source suppliers, inventory forecasting, competition, international trade restrictions and tariffs, foreign exchange, and disruption to manufacturing or customer operations. The filing specifically noted potential effects of the novel coronavirus outbreak on China and Taiwan.
- Other notable items: The company reserved $2.0 million against a $5.0 million convertible note receivable from Simax and stopped accruing interest on it after September 30, 2019. An $80 million share-repurchase authorization was available after the merger; no purchases under that authorization were reported by year-end.
- Controls and contingencies: Management and the auditor concluded internal control over financial reporting was effective, but Nanometrics was excluded from the control evaluations; it represented 26% of year-end assets and 22% of 2019 revenue. A continuing OSI lawsuit was not expected by management to have a material financial impact; merger-related shareholder actions were closed after immaterial mootness-fee payments.
Investor verification priorities
- Reconcile reported 2019 results with the merger’s purchase accounting and review the unaudited pro forma figures: pro forma revenue was $525.5 million for 2019 and $598.3 million for 2018, with pro forma net income of $0.9 million and $36.2 million, respectively.
- Assess whether gross margins and operating cash flow recover after inventory step-up and excess-inventory charges, and monitor inventory levels and reserves.
- Verify the timing and realized benefits of integration, including cost savings, revenue synergies, and retention of customers and key personnel.
- Monitor customer concentration, backlog conversion and semiconductor spending, particularly in China and Taiwan, alongside trade and public-health developments.
- Review collectability of the Simax note, tax uncertainties, and the status of the OSI litigation and other commitments.